乳腺癌攻坚最核心战场,爆款正在酝酿

医曜
Nov 28, 2025

核心产品Entresto迎来专利悬崖,诺华无疑将遭遇严峻考验。然而,诺华不仅没有退缩,甚至进一步上调业绩指引。尤其是对于乳腺癌治疗药物Kisqali,诺华更是将其销售峰值上调至100亿美元,成为诺华历史上预期峰值最高的药物。乳腺癌作为是女性发病率最高的恶性肿瘤,全球每年新增乳腺癌患者超230万人,而HR+/HER2- 乳腺癌又是占比最高的分型,约占总患者数的70%,堪称乳腺癌攻坚最核心战场。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10